Etiology of Bacterial Meningitis Among Children <5 Years Old in Côte d’Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction

• Published in: Clinical infectious diseases Vol. 69; no. Supplement_2; pp. S114 - S120
• Main Authors: Boni-Cisse, Catherine, Jarju, Sheikh, Bancroft, Rowan E, Lepri, Nicaise A, Kone, Hamidou, Kofi, N’zue, Britoh-Mlan, Alice, Zaba, Flore Sandrine, Usuf, Effua, Ndow, Peter Sylvanus, Worwui, Archibald, Mwenda, Jason M, Biey, Joseph N, Ntsama, Bernard, Kwambana-Adams, Brenda A, Antonio, Martin
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 05.09.2019
• Subjects: Supplement; pneumococcus; meningitis; Côte d’Ivoire; pediatric; Haemophilus influenzae
• ISSN: 1058-4838; 1537-6591
• DOI: 10.1093/cid/ciz475

Abstract Background Bacterial meningitis remains a major disease affecting children in Côte d’Ivoire. Thus, with support from the World Health Organization (WHO), Côte d’Ivoire has implemented pediatric bacterial meningitis (PBM) surveillance at 2 sentinel hospitals in Abidjan, targeting the main causes of PBM: Streptococcus pneumoniae (pneumococcus), Haemophilus influenzae, and Neisseria meningitidis (meningococcus). Herein we describe the epidemiological characteristics of PBM observed in Côte d’Ivoire during 2010–2016. Methods Cerebrospinal fluid (CSF) was collected from children aged <5 years admitted to the Abobo General Hospital or University Hospital Center Yopougon with suspected meningitis. Microbiology and polymerase chain reaction (PCR) techniques were used to detect the presence of pathogens in CSF. Where possible, serotyping/grouping was performed to determine the specific causative agents. Results Overall, 2762 cases of suspected meningitis were reported, with CSF from 39.2% (1083/2762) of patients analyzed at the WHO regional reference laboratory in The Gambia. In total, 82 (3.0% [82/2762]) CSF samples were positive for bacterial meningitis. Pneumococcus was the main pathogen responsible for PBM, accounting for 69.5% (52/82) of positive cases. Pneumococcal conjugate vaccine serotypes 5, 18C, 19F, and 6A/B were identified post–vaccine introduction. Emergence of H. influenzae nontypeable meningitis was observed after H. influenzae type b vaccine introduction. Conclusions Despite widespread use and high coverage of conjugate vaccines, pneumococcal vaccine serotypes and H. influenzae type b remain associated with bacterial meningitis among children aged <5 years in Côte d’Ivoire. This reinforces the need for enhanced surveillance for vaccine-preventable diseases to determine the prevalence of bacterial meningitis and vaccine impact across the country. Longitudinal sentinel surveillance at 2 hospitals within Abidjan, Côte d’Ivoire, during 2010–2016 revealed that Streptococcus pneumoniae was the predominant pathogen responsible for pediatric bacterial meningitis before and after the introduction of the 13-valent pneumococcal conjugate vaccine.